# Serafin Morales Murillo, PhD, M.D. – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/serafin-morales-murillo-phd-md/89b908ed-33ea-4cda-989b-869f37634c60
Source feed: FDA_Inspections

> FDA inspection 1214514 of Serafin Morales Murillo, PhD, M.D., July 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214514
- Company Name: Serafin Morales Murillo, PhD, M.D.
- Inspection Date: 2023-07-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-l-rakestraw/ca138abf-e5d4-43ca-b9d2-79ea6294a8c8)

Company: https://www.keypedia.com/companies/serafin-morales-murillo-phd-md/b3f057d0-0fa4-4aec-a92f-0e89518b14a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c